nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—L-DOPA—Melphalan—peripheral nervous system neoplasm	0.383	1	CrCrCtD
Norepinephrine—SLC22A3—Melphalan—peripheral nervous system neoplasm	0.211	0.492	CbGbCtD
Norepinephrine—SLC22A5—Dactinomycin—peripheral nervous system neoplasm	0.063	0.147	CbGbCtD
Norepinephrine—SLC22A3—Vincristine—peripheral nervous system neoplasm	0.0625	0.146	CbGbCtD
Norepinephrine—SLC22A2—Cisplatin—peripheral nervous system neoplasm	0.0345	0.0804	CbGbCtD
Norepinephrine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0264	0.0615	CbGbCtD
Norepinephrine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0211	0.0492	CbGbCtD
Norepinephrine—Violent—Isotretinoin—peripheral nervous system neoplasm	0.0174	0.158	CcSEcCtD
Norepinephrine—Violent—Tretinoin—peripheral nervous system neoplasm	0.0174	0.158	CcSEcCtD
Norepinephrine—Violent—Alitretinoin—peripheral nervous system neoplasm	0.0132	0.119	CcSEcCtD
Norepinephrine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0103	0.0241	CbGbCtD
Norepinephrine—Lactic acidosis—Epirubicin—peripheral nervous system neoplasm	0.00222	0.0202	CcSEcCtD
Norepinephrine—Lactic acidosis—Doxorubicin—peripheral nervous system neoplasm	0.00206	0.0187	CcSEcCtD
Norepinephrine—Pallor—Isotretinoin—peripheral nervous system neoplasm	0.00197	0.0179	CcSEcCtD
Norepinephrine—Pallor—Tretinoin—peripheral nervous system neoplasm	0.00197	0.0179	CcSEcCtD
Norepinephrine—Extravasation—Topotecan—peripheral nervous system neoplasm	0.00189	0.0172	CcSEcCtD
Norepinephrine—Aggression—Isotretinoin—peripheral nervous system neoplasm	0.00186	0.0169	CcSEcCtD
Norepinephrine—Aggression—Tretinoin—peripheral nervous system neoplasm	0.00186	0.0169	CcSEcCtD
Norepinephrine—Extravasation—Melphalan—peripheral nervous system neoplasm	0.00185	0.0168	CcSEcCtD
Norepinephrine—Photophobia—Isotretinoin—peripheral nervous system neoplasm	0.00154	0.0139	CcSEcCtD
Norepinephrine—Photophobia—Tretinoin—peripheral nervous system neoplasm	0.00154	0.0139	CcSEcCtD
Norepinephrine—Extravasation—Dactinomycin—peripheral nervous system neoplasm	0.00153	0.0139	CcSEcCtD
Norepinephrine—Pallor—Alitretinoin—peripheral nervous system neoplasm	0.0015	0.0136	CcSEcCtD
Norepinephrine—Aggression—Alitretinoin—peripheral nervous system neoplasm	0.00141	0.0128	CcSEcCtD
Norepinephrine—Extravasation—Vincristine—peripheral nervous system neoplasm	0.00137	0.0124	CcSEcCtD
Norepinephrine—Retrosternal pain—Epirubicin—peripheral nervous system neoplasm	0.00135	0.0122	CcSEcCtD
Norepinephrine—Retrosternal pain—Doxorubicin—peripheral nervous system neoplasm	0.00125	0.0113	CcSEcCtD
Norepinephrine—Extravasation—Cisplatin—peripheral nervous system neoplasm	0.00121	0.011	CcSEcCtD
Norepinephrine—Photophobia—Alitretinoin—peripheral nervous system neoplasm	0.00116	0.0106	CcSEcCtD
Norepinephrine—Extravasation—Etoposide—peripheral nervous system neoplasm	0.00111	0.0101	CcSEcCtD
Norepinephrine—POU5F1—cerebellum—peripheral nervous system neoplasm	0.000889	0.165	CbGeAlD
Norepinephrine—Sweating—Topotecan—peripheral nervous system neoplasm	0.000885	0.00803	CcSEcCtD
Norepinephrine—Sweating—Isotretinoin—peripheral nervous system neoplasm	0.000878	0.00796	CcSEcCtD
Norepinephrine—Sweating—Tretinoin—peripheral nervous system neoplasm	0.000878	0.00796	CcSEcCtD
Norepinephrine—Arrhythmia—Isotretinoin—peripheral nervous system neoplasm	0.000734	0.00666	CcSEcCtD
Norepinephrine—Arrhythmia—Tretinoin—peripheral nervous system neoplasm	0.000734	0.00666	CcSEcCtD
Norepinephrine—Arrhythmia—Melphalan—peripheral nervous system neoplasm	0.000725	0.00658	CcSEcCtD
Norepinephrine—Sweating—Alitretinoin—peripheral nervous system neoplasm	0.000665	0.00604	CcSEcCtD
Norepinephrine—Sweating—Vincristine—peripheral nervous system neoplasm	0.000641	0.00582	CcSEcCtD
Norepinephrine—Extravasation—Epirubicin—peripheral nervous system neoplasm	0.000622	0.00564	CcSEcCtD
Norepinephrine—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.000618	0.0056	CcSEcCtD
Norepinephrine—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.000618	0.0056	CcSEcCtD
Norepinephrine—Chest pain—Topotecan—peripheral nervous system neoplasm	0.000614	0.00557	CcSEcCtD
Norepinephrine—Chest pain—Isotretinoin—peripheral nervous system neoplasm	0.000609	0.00553	CcSEcCtD
Norepinephrine—Chest pain—Tretinoin—peripheral nervous system neoplasm	0.000609	0.00553	CcSEcCtD
Norepinephrine—Anxiety—Tretinoin—peripheral nervous system neoplasm	0.000607	0.00551	CcSEcCtD
Norepinephrine—Anxiety—Isotretinoin—peripheral nervous system neoplasm	0.000607	0.00551	CcSEcCtD
Norepinephrine—Chest pain—Melphalan—peripheral nervous system neoplasm	0.000601	0.00545	CcSEcCtD
Norepinephrine—Extravasation—Doxorubicin—peripheral nervous system neoplasm	0.000576	0.00522	CcSEcCtD
Norepinephrine—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.000569	0.00516	CcSEcCtD
Norepinephrine—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.000565	0.00512	CcSEcCtD
Norepinephrine—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.000565	0.00512	CcSEcCtD
Norepinephrine—Arrhythmia—Alitretinoin—peripheral nervous system neoplasm	0.000557	0.00505	CcSEcCtD
Norepinephrine—Bradycardia—Cisplatin—peripheral nervous system neoplasm	0.00054	0.0049	CcSEcCtD
Norepinephrine—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.000525	0.00476	CcSEcCtD
Norepinephrine—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.000521	0.00472	CcSEcCtD
Norepinephrine—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.000521	0.00472	CcSEcCtD
Norepinephrine—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.000514	0.00466	CcSEcCtD
Norepinephrine—SLC18A2—ganglion—peripheral nervous system neoplasm	0.00049	0.091	CbGeAlD
Norepinephrine—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.000474	0.0043	CcSEcCtD
Norepinephrine—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.000468	0.00425	CcSEcCtD
Norepinephrine—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.000462	0.00419	CcSEcCtD
Norepinephrine—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.00046	0.00417	CcSEcCtD
Norepinephrine—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000451	0.00409	CcSEcCtD
Norepinephrine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000428	0.00388	CcSEcCtD
Norepinephrine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000412	0.00374	CcSEcCtD
Norepinephrine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000395	0.00358	CcSEcCtD
Norepinephrine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000392	0.00356	CcSEcCtD
Norepinephrine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000374	0.0034	CcSEcCtD
Norepinephrine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000371	0.00337	CcSEcCtD
Norepinephrine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000371	0.00337	CcSEcCtD
Norepinephrine—Headache—Topotecan—peripheral nervous system neoplasm	0.000369	0.00335	CcSEcCtD
Norepinephrine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000367	0.00332	CcSEcCtD
Norepinephrine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000366	0.00332	CcSEcCtD
Norepinephrine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000366	0.00332	CcSEcCtD
Norepinephrine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000366	0.00332	CcSEcCtD
Norepinephrine—SLC22A1—ganglion—peripheral nervous system neoplasm	0.000365	0.0678	CbGeAlD
Norepinephrine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000365	0.00331	CcSEcCtD
Norepinephrine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00036	0.00327	CcSEcCtD
Norepinephrine—SLC22A3—tongue—peripheral nervous system neoplasm	0.000345	0.0641	CbGeAlD
Norepinephrine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000336	0.00305	CcSEcCtD
Norepinephrine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000334	0.00303	CcSEcCtD
Norepinephrine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000308	0.00279	CcSEcCtD
Norepinephrine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000304	0.00275	CcSEcCtD
Norepinephrine—SLC6A2—nerve—peripheral nervous system neoplasm	0.000303	0.0562	CbGeAlD
Norepinephrine—SLC6A2—ganglion—peripheral nervous system neoplasm	0.000299	0.0555	CbGeAlD
Norepinephrine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000291	0.00264	CcSEcCtD
Norepinephrine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000281	0.00255	CcSEcCtD
Norepinephrine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000278	0.00252	CcSEcCtD
Norepinephrine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000277	0.00252	CcSEcCtD
Norepinephrine—DRD2—nerve—peripheral nervous system neoplasm	0.000276	0.0512	CbGeAlD
Norepinephrine—DRD2—ganglion—peripheral nervous system neoplasm	0.000273	0.0506	CbGeAlD
Norepinephrine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000271	0.00246	CcSEcCtD
Norepinephrine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000269	0.00244	CcSEcCtD
Norepinephrine—Headache—Vincristine—peripheral nervous system neoplasm	0.000267	0.00242	CcSEcCtD
Norepinephrine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.00233	CcSEcCtD
Norepinephrine—SLC22A2—trigeminal ganglion—peripheral nervous system neoplasm	0.000254	0.0471	CbGeAlD
Norepinephrine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000244	0.00221	CcSEcCtD
Norepinephrine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00024	0.00218	CcSEcCtD
Norepinephrine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.00204	CcSEcCtD
Norepinephrine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00022	0.00199	CcSEcCtD
Norepinephrine—Headache—Etoposide—peripheral nervous system neoplasm	0.000216	0.00196	CcSEcCtD
Norepinephrine—SLC18A2—brainstem—peripheral nervous system neoplasm	0.000213	0.0395	CbGeAlD
Norepinephrine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000205	0.00186	CcSEcCtD
Norepinephrine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000202	0.00183	CcSEcCtD
Norepinephrine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000201	0.00183	CcSEcCtD
Norepinephrine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.00172	CcSEcCtD
Norepinephrine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000187	0.0017	CcSEcCtD
Norepinephrine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.0017	CcSEcCtD
Norepinephrine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.00169	CcSEcCtD
Norepinephrine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.00157	CcSEcCtD
Norepinephrine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000173	0.00157	CcSEcCtD
Norepinephrine—SLC22A3—trigeminal ganglion—peripheral nervous system neoplasm	0.000172	0.0318	CbGeAlD
Norepinephrine—SLC22A3—parotid gland—peripheral nervous system neoplasm	0.000162	0.03	CbGeAlD
Norepinephrine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.00145	CcSEcCtD
Norepinephrine—ADRA2C—trigeminal ganglion—peripheral nervous system neoplasm	0.00013	0.0242	CbGeAlD
Norepinephrine—SLC6A2—brainstem—peripheral nervous system neoplasm	0.00013	0.0241	CbGeAlD
Norepinephrine—SLC22A5—trigeminal ganglion—peripheral nervous system neoplasm	0.000125	0.0231	CbGeAlD
Norepinephrine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000123	0.00112	CcSEcCtD
Norepinephrine—ADRA2C—parotid gland—peripheral nervous system neoplasm	0.000123	0.0228	CbGeAlD
Norepinephrine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000121	0.0011	CcSEcCtD
Norepinephrine—ADRA1A—brainstem—peripheral nervous system neoplasm	0.000121	0.0224	CbGeAlD
Norepinephrine—DRD2—brainstem—peripheral nervous system neoplasm	0.000119	0.022	CbGeAlD
Norepinephrine—SLC22A5—parotid gland—peripheral nervous system neoplasm	0.000118	0.0218	CbGeAlD
Norepinephrine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.00103	CcSEcCtD
Norepinephrine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.00102	CcSEcCtD
Norepinephrine—SLC18A2—cerebellum—peripheral nervous system neoplasm	0.000105	0.0195	CbGeAlD
Norepinephrine—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.000104	0.0193	CbGeAlD
Norepinephrine—ADRA1A—cerebellum—peripheral nervous system neoplasm	5.96e-05	0.0111	CbGeAlD
Norepinephrine—DRD2—cerebellum—peripheral nervous system neoplasm	5.84e-05	0.0108	CbGeAlD
Norepinephrine—ADRA2C—cerebellum—peripheral nervous system neoplasm	5.68e-05	0.0105	CbGeAlD
Norepinephrine—SLC22A5—cerebellum—peripheral nervous system neoplasm	5.44e-05	0.0101	CbGeAlD
Norepinephrine—ADRA2A—cerebellum—peripheral nervous system neoplasm	4.53e-05	0.00841	CbGeAlD
Norepinephrine—SLC22A1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	2.14e-05	0.000294	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.14e-05	0.000293	CbGpPWpGaD
Norepinephrine—DRD2—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	2.11e-05	0.00029	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.11e-05	0.000289	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2.1e-05	0.000288	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—ENO2—peripheral nervous system neoplasm	2.09e-05	0.000286	CbGpPWpGaD
Norepinephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	2.08e-05	0.000285	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	2.07e-05	0.000284	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2.07e-05	0.000283	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—VIP—peripheral nervous system neoplasm	2.07e-05	0.000283	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	2.04e-05	0.00028	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2e-05	0.000274	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	2e-05	0.000274	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	2e-05	0.000274	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.99e-05	0.000273	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.97e-05	0.00027	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—PTPN11—peripheral nervous system neoplasm	1.97e-05	0.000269	CbGpPWpGaD
Norepinephrine—ADRA2B—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.95e-05	0.000267	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.92e-05	0.000264	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.91e-05	0.000261	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.89e-05	0.000259	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.87e-05	0.000256	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.86e-05	0.000254	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.85e-05	0.000254	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.85e-05	0.000253	CbGpPWpGaD
Norepinephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.85e-05	0.000253	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—BCHE—peripheral nervous system neoplasm	1.84e-05	0.000252	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.84e-05	0.000252	CbGpPWpGaD
Norepinephrine—PAH—Disease—HRAS—peripheral nervous system neoplasm	1.83e-05	0.000251	CbGpPWpGaD
Norepinephrine—ADRA2C—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.82e-05	0.00025	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.81e-05	0.000248	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.8e-05	0.000247	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.79e-05	0.000245	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—TH—peripheral nervous system neoplasm	1.78e-05	0.000244	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—ENO2—peripheral nervous system neoplasm	1.77e-05	0.000242	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—BCHE—peripheral nervous system neoplasm	1.76e-05	0.000242	CbGpPWpGaD
Norepinephrine—SLC22A2—Neuronal System—HRAS—peripheral nervous system neoplasm	1.76e-05	0.000241	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.75e-05	0.00024	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.75e-05	0.000239	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—TH—peripheral nervous system neoplasm	1.73e-05	0.000237	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.71e-05	0.000234	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.71e-05	0.000234	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.69e-05	0.000232	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.68e-05	0.00023	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.67e-05	0.000229	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—TH—peripheral nervous system neoplasm	1.66e-05	0.000227	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.65e-05	0.000226	CbGpPWpGaD
Norepinephrine—SLC22A1—Neuronal System—HRAS—peripheral nervous system neoplasm	1.64e-05	0.000225	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.62e-05	0.000222	CbGpPWpGaD
Norepinephrine—PAH—Disease—AKT1—peripheral nervous system neoplasm	1.62e-05	0.000222	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	1.61e-05	0.000221	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.6e-05	0.000219	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.58e-05	0.000216	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—NRAS—peripheral nervous system neoplasm	1.56e-05	0.000213	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.55e-05	0.000213	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	1.54e-05	0.000212	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.53e-05	0.000209	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.52e-05	0.000208	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.5e-05	0.000206	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—BCHE—peripheral nervous system neoplasm	1.49e-05	0.000205	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.49e-05	0.000205	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	1.49e-05	0.000204	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.49e-05	0.000204	CbGpPWpGaD
Norepinephrine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.48e-05	0.000203	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.47e-05	0.000201	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.46e-05	0.0002	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—NRAS—peripheral nervous system neoplasm	1.45e-05	0.000199	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.45e-05	0.000199	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.45e-05	0.000198	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.43e-05	0.000196	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.43e-05	0.000196	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.43e-05	0.000195	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.42e-05	0.000195	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—GNAS—peripheral nervous system neoplasm	1.41e-05	0.000193	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—TH—peripheral nervous system neoplasm	1.4e-05	0.000192	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.4e-05	0.000192	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.39e-05	0.00019	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.39e-05	0.00019	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—ABCB1—peripheral nervous system neoplasm	1.39e-05	0.00019	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.38e-05	0.000189	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.38e-05	0.000189	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.37e-05	0.000187	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.36e-05	0.000186	CbGpPWpGaD
Norepinephrine—PAH—Metabolism—AKT1—peripheral nervous system neoplasm	1.36e-05	0.000186	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—GNAS—peripheral nervous system neoplasm	1.35e-05	0.000185	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.35e-05	0.000185	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.33e-05	0.000182	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.33e-05	0.000182	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.29e-05	0.000176	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.28e-05	0.000176	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.28e-05	0.000175	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.27e-05	0.000174	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.26e-05	0.000173	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.26e-05	0.000173	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.25e-05	0.000171	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.22e-05	0.000168	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.21e-05	0.000166	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—TP53—peripheral nervous system neoplasm	1.19e-05	0.000163	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—NRAS—peripheral nervous system neoplasm	1.18e-05	0.000162	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.18e-05	0.000162	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.18e-05	0.000162	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.18e-05	0.000162	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.17e-05	0.00016	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.16e-05	0.000159	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—GNAS—peripheral nervous system neoplasm	1.15e-05	0.000157	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—HRAS—peripheral nervous system neoplasm	1.14e-05	0.000156	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.13e-05	0.000155	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—ABCB1—peripheral nervous system neoplasm	1.13e-05	0.000154	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.12e-05	0.000154	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—TP53—peripheral nervous system neoplasm	1.11e-05	0.000153	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.11e-05	0.000152	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.1e-05	0.00015	CbGpPWpGaD
Norepinephrine—ADRB3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.08e-05	0.000148	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.07e-05	0.000147	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.07e-05	0.000147	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—HRAS—peripheral nervous system neoplasm	1.06e-05	0.000146	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.04e-05	0.000143	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.03e-05	0.000141	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—AKT1—peripheral nervous system neoplasm	1.01e-05	0.000138	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.9e-06	0.000136	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	9.82e-06	0.000135	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	9.76e-06	0.000134	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.73e-06	0.000133	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	9.59e-06	0.000131	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—AKT1—peripheral nervous system neoplasm	9.4e-06	0.000129	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	9.04e-06	0.000124	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.02e-06	0.000124	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.98e-06	0.000123	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.94e-06	0.000122	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.86e-06	0.000121	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.83e-06	0.000121	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.78e-06	0.00012	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.67e-06	0.000119	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	8.65e-06	0.000118	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.36e-06	0.000115	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.35e-06	0.000114	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	8.25e-06	0.000113	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.22e-06	0.000113	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.2e-06	0.000112	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.07e-06	0.000111	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.87e-06	0.000108	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	7.75e-06	0.000106	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.69e-06	0.000105	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	7.63e-06	0.000105	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.58e-06	0.000104	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.44e-06	0.000102	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.3e-06	0.0001	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.24e-06	9.93e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.17e-06	9.83e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.04e-06	9.65e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7e-06	9.6e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.98e-06	9.56e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.94e-06	9.51e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.87e-06	9.41e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.85e-06	9.39e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.78e-06	9.29e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.66e-06	9.13e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.6e-06	9.04e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.57e-06	9e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.54e-06	8.96e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.48e-06	8.88e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.46e-06	8.85e-05	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.42e-06	8.79e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.4e-06	8.76e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.38e-06	8.74e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.36e-06	8.71e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.36e-06	8.71e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	6.33e-06	8.67e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.3e-06	8.63e-05	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.28e-06	8.6e-05	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—AKT1—peripheral nervous system neoplasm	6.25e-06	8.56e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.22e-06	8.52e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	6.21e-06	8.51e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.11e-06	8.37e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.01e-06	8.24e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.94e-06	8.14e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.88e-06	8.06e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.88e-06	8.06e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.85e-06	8.02e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.85e-06	8.01e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.83e-06	7.99e-05	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.8e-06	7.95e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.79e-06	7.94e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.77e-06	7.91e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.7e-06	7.81e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.67e-06	7.77e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.54e-06	7.6e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.45e-06	7.47e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.39e-06	7.39e-05	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.39e-06	7.39e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.34e-06	7.32e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.34e-06	7.32e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.33e-06	7.3e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.31e-06	7.27e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.28e-06	7.24e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.27e-06	7.22e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.21e-06	7.14e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.19e-06	7.12e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.14e-06	7.05e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.96e-06	6.8e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.96e-06	6.8e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.93e-06	6.76e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.92e-06	6.74e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.89e-06	6.71e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.86e-06	6.65e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.85e-06	6.65e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.82e-06	6.61e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.78e-06	6.55e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.72e-06	6.46e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.59e-06	6.3e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.52e-06	6.2e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.48e-06	6.13e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.47e-06	6.13e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.38e-06	6e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.31e-06	5.91e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.28e-06	5.86e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.17e-06	5.71e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.08e-06	5.59e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.04e-06	5.54e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.02e-06	5.5e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.01e-06	5.49e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.99e-06	5.46e-05	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—AKT1—peripheral nervous system neoplasm	3.92e-06	5.37e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.9e-06	5.34e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.86e-06	5.29e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.81e-06	5.23e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—AKT1—peripheral nervous system neoplasm	3.81e-06	5.22e-05	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.78e-06	5.18e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.77e-06	5.17e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.73e-06	5.11e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.71e-06	5.09e-05	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—AKT1—peripheral nervous system neoplasm	3.65e-06	5e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.61e-06	4.94e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.55e-06	4.87e-05	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.44e-06	4.72e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.42e-06	4.69e-05	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.41e-06	4.67e-05	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.37e-06	4.61e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.3e-06	4.52e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.27e-06	4.49e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.19e-06	4.37e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.15e-06	4.32e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.14e-06	4.3e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	3.1e-06	4.24e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.06e-06	4.2e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.93e-06	4.02e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.89e-06	3.96e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.79e-06	3.82e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.59e-06	3.55e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.71e-06	2.34e-05	CbGpPWpGaD
